Table 1 Patient data and characteristics of the examined colon carcinoma cell lines and xenografts
cell line | Patient Data | CEA secreting | source | ||||
|---|---|---|---|---|---|---|---|
| Â | Â | differentiation | gender | age | Dukes Stage | [ng/106 cells] | Â |
HTC116 | primary | poorly | male | 50 | n.k. | 1 | ATCC |
LOVO | metastasis | well | male | 56 | C | 908 | ATCC |
HT29 | primary | middle | female | 44 | n.k. | yes | NCI |
SW620 | metastasis | poorly | male | 51 | C | 0,15 | NCI |
DLD1 | primary | middle | male | 50 | C | 0,5 | NCI |
HCT15 | primary | middle | male | 50 | C | 5,4 | ATCC |
SW480 | primary | middle | male | 50 | B | 0,7 | NCI |
269 L | primary | poorly | male | 56 | C | n.k. | Oncotest |
94 L | primary | middle | male | 70 | n.k. | n.k. | Oncotest |
COLO205 | metastasis | poorly | male | 70 | D | 4,1 | NCI |
HCC2998 | primary | well | n.k. | n.k. | n.k. | n.k. | NCI |
KM12 | primary | poorly | n.k. | n.k. | B | n.k. | NCI |
KM20 | primary | poorly | n.k. | n.k. | D | n.k. | NCI |
LS174T | primary | middle | female | 58 | B | 1994 | ATCC |
CXF 269 | primary | poorly | male | 56 | C | n.k. | Oncotest |
CXF 243 | primary | poorly | male | 45 | n.k. | n.k. | Oncotest |
CXF 280 | metastasis | poorly | female | 56 | n.k. | n.k. | Oncotest |
CXF 1103 | primary | poorly | male | 56 | n.k. | n.k. | Oncotest |